Talphera (TLPH) Return on Capital Employed (2011 - 2026)
Talphera (TLPH) posted quarterly Return on Capital Employed of 56.02% for Q1 2026, up 3922.0% year-over-year from 1.39% in Q1 2025, and down 9.77% quarter-over-quarter from 51.03% in Q4 2025.
Talphera (TLPH) Return on Capital Employed (2011 - 2026) Analysis & Trends
Talphera's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 56.02% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 3922.0% year-over-year to 56.02%; the TTM figure through Mar 2026 stood at 56.02% (up 3922.0% YoY), while the FY2025 annual figure was 66.86%, up 2465.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 56.02%, down from 51.03% in the prior quarter.
- The five-year high for Return on Capital Employed was 51.03% in Q4 2025, with the low at 101.74% in Q2 2025.
- The 5-year median for Return on Capital Employed is 77.13% (2022), against an average of 76.36%.
- The sharpest annual moves came in 2025 and 2026: Return on Capital Employed plunged 3335 bps in 2025, then soared 3922 bps in 2026.
- Talphera's Return on Capital Employed stood at 86.02% in 2022, then rose by 21 bps to 67.98% in 2023, then sank by 32 bps to 89.83% in 2024, then jumped by 43 bps to 51.03% in 2025, then declined by 10 bps to 56.02% in 2026.
- Business Quant data shows TLPH's Return on Capital Employed at 56.02% in Q1 2026, 51.03% in Q4 2025, and 63.81% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Talphera | 90.35 Mn | 90.35 Mn | - | -60.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -60.71% |
| Mar 31, 2026 | -56.02% |
| Dec 31, 2025 | -51.03% |
| Sep 30, 2025 | -63.81% |
| Jun 30, 2025 | -101.74% |
| Mar 31, 2025 | -95.24% |
| Dec 31, 2024 | -89.83% |
| Sep 30, 2024 | -81.99% |
| Jun 30, 2024 | -68.39% |
| Mar 31, 2024 | -74.38% |
| Dec 31, 2023 | -67.98% |
| Sep 30, 2023 | -79.05% |
| Jun 30, 2023 | -82.01% |
| Mar 31, 2023 | -75.02% |
| Dec 31, 2022 | -86.02% |
| Sep 30, 2022 | -86.54% |
| Jun 30, 2022 | -77.13% |
| Mar 31, 2022 | -61.86% |
| Dec 31, 2021 | -63.58% |
| Sep 30, 2021 | -62.92% |